Uncategorized

Transcenta Anti-sclerostin Monoclonal Antibody TST002 (Blosozumab) Received Approval from China CDE to Initiate Phase II Clinical Trial in Patients with Reduced Bone Mineral Density

Transcenta Holding Limited announces that it has received approval from China Center for Drug Evaluation to initiate Phase II clinical trial of TST002.

Transcenta Anti-sclerostin Monoclonal Antibody TST002 (Blosozumab) Received Approval from China CDE to Initiate Phase II Clinical Trial in Patients with Reduced Bone Mineral Density Read More »

U.S. FDA Accepts Biologics License Application for GC Biopharma’s GC5107B (Immune Globulin Intravenous (Human), 10% Liquid)

GC Biopharma, a global biopharmaceutical company dedicated to specialty plasma-derived therapeutics, announced that the U.S. Food and Drug Administration has accepted the Company’s resubmission of the Biologics License Application for its GC5107B for patients with primary humoral immunodeficiency.

U.S. FDA Accepts Biologics License Application for GC Biopharma’s GC5107B (Immune Globulin Intravenous (Human), 10% Liquid) Read More »

Choza hecha de hongos

La estructura dentro de la cual se refugia esta pareja, y que recuerda un poco al armazón para un tipi (la choza tradicional de los indios norteamericanos) o para una tienda de campaña, está hecha de un material elaborado a base de hongos.   El material ha sido dise&ntild …

Choza hecha de hongos Read More »

Scroll to Top